Burleson & Company, LLC Abbott Laboratories Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Burleson & Company, LLC holds 12,569 shares of ABT stock, worth $1.5 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

12,569

Previous 12,569 -0.0%

Holding current value

$1.5 Million

Previous $1.22 Million 13.49%

% of portfolio

0.36%

Previous 0.26%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$115.53 - $141.46 $9,011 - $11,033	-78 Reduced 0.62%	12,569 $1.77 Million
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $18,513 - $21,792	-175 Reduced 1.36%	12,647 $1.47 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $21,768 - $25,645	200 Added 1.58%	12,822 $1.54 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $15,855 - $17,277	151 Added 1.21%	12,622 $1.38 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $458,291 - $556,561	-5,001 Reduced 28.62%	12,471 $1.43 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $765 - $980	10 Added 0.06%	17,472 $1.77 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $3,203 - $4,684	51 Added 0.29%	17,462 $1.64 Million
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $4,445 - $5,185	61 Added 0.35%	17,411 $1.5 Million
Q3 2018 Dec 06, 2018	BUY	$60.81 - $73.36 $60 - $73	1 Added 0.01%	17,350 $1.22 Million
Q2 2018 Jul 31, 2018	BUY	$57.57 - $63.54 $57,570 - $63,540	1,000 Added 6.12%	17,349 $1.06 Million
Q4 2017 Mar 19, 2018	BUY	$53.68 - $57.47 $877,614 - $939,577	16,349	16,349 $933,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Abbott Laboratories Transaction History